References
- Gold P, Freedman S O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439–459
- Gold P, Freedman S O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122: 467–481
- Lo Gerfo P, Krupey J, Hansen H J. Demonstration of an antigen common to several varieties of neoplasia. N Engl J Med 1971; 285: 138–141
- Thomson D MP, Krupey J, Freedman S O, Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci 1969; 64: 161–167
- Mach J P, Pusztaszeri G, Dysli M, Kapp F, Bierens de Haan B, Loosli R M, Grob P, Isliker H. Der radioimmunologische Nachweis des Carcino-Embryonic-Antigens (CEA) im Plasma von Karzinompatienten. Schweiz Med Wochenschr 1973; 103: 365–371
- Carcinoembryonic antigen (CEA) test collaborative study, 3rd Conference. 1973. Hoffman-LaRoche Inc., BaselSwitzerland 1973
- Moore T, Kantrowitz P A, Zamcheck N. Carcinoembryonic antigen (CEA) in inflammatory bowel disease. JAMA 1972; 222: 944–947
- Rule A H, Straus E, Vandervoorde J, Janowitz H D. Tumorassociated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med 1972; 287: 24–26
- Moore T, Dhar P, Zamcheck N, Keeley A, Gottlieb L, Kupchik H Z. Carcinoembryonic antigen(s) in liver disease. I. Clinical and morphological studies. Gastroenterology 1972; 63: 88–94
- Kupchik H Z, Zamcheck N. Carcinoembryonic antigen(s) in liver disease. II. Isolation from human cirrhotic liver and serum and from normal liver. Gastroenterology 1972; 63: 95–101
- Booth S N, King J PG, Leonard J C, Dykes P W. Serum carcinoembryonic antigen in clinical disorders. Gut 1973; 14: 794–799
- Wagener C. Diagnostic sensitivity, diagnostic specificity and predictive value of the determination of tumour markers. J Clin Chem Clin Biochem 1984; 22: 969–979
- Nap M, Fleuren G J. Immunohistochemical demonstration of carcinoembryonic antigen in lung cancer, its localization in relation to tumor type and differentiation. Protides of the biological fluids, H Peeters. Pergamon Press, Oxford 1983; 31: 333–335
- Wachner R, Wittekinnd C, von Kleist S. Localisation of CEA, β-hCG, SP1 and keratin in the tissue of lung carcinomas. Virchows Archiv (Pathol Anat) 1984; 402: 415–423
- Concannon J P, Dalbow M H, Liebler G A, Blake K E, Weil C S, Cooper J W. The carcinoembryonic antigen assay in bronchogenic carcinoma. Cancer 1974; 34: 184–192
- Rasmuson T, Björk G R, Damber L, Holm S E, Jacobsson L, Jeppsson A, Stigbrand T, Westman G. Tumor markers in bronchogenic carcinoma. Acta Radiol Oncol 1983; 22: 209–214
- Johansson B G. Plasmaproteiner i laboratoriediagnostiken. Plasmaproteiner, B Blombäck, L HansonÀ. AWE Gebers, UddevallaSweden 1976; 343–360
- Schreiber G, Howlett G, Nagashima M, Millership A, Martin H, Urban J, Kotler L. The acute phase response of plasma protein synthesis during experimental inflammation. J Biol Chem 1982; 257: 10271–10275